REG - Cambridge Cognition - Result of AGM

Cambridge Cognition HoldingsAnnouncement

Yesterday 12:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250627:nRSa7888Oa&default-theme=true

RNS Number : 7888O  Cambridge Cognition Holdings PLC  27 June 2025

27 June 2025

 

Cambridge Cognition Holdings plc

("Cambridge Cognition", the "Company" or the "Group")

 

Result of AGM

 

Cambridge Cognition Holdings plc, the brain health software group specialising
in digital health products that advance brain health research and treatment,
held its Annual General Meeting ("AGM") earlier today at the registered office
of the Company; Tunbridge Court, Tunbridge Lane, Bottisham, Cambridge, CB25
9TU and announces that all resolutions put forward were duly passed.

 

Proxy votes were received in respect of 67.6% of the Company's issued share
capital. The votes cast were as follows:

 

     Resolution                                                    Votes For   Percent of votes cast For  Votes Against  Percent of votes cast Against  Votes Withheld
 1   To approve the 2024 Report and Accounts                       28,372,450  100%                       -              -                              -
 2   To approve the 2024 Directors' Remuneration Report(1)         28,346,127  99.91%                     25,315         0.09%                          1,008
 3   To approve the Directors' Remuneration Policy(1)              28,346,127  99.91%                     25,315         0.09%                          1,008
 4   To re-appoint the auditors                                    28,359,763  99.99%                     3,500          0.01%                          9,187
 5   To authorise the directors to set the auditors' remuneration  28,370,475  100%                       -              -                              1,975
 6   To re-elect Steven Powell as a director                       28,369,043  100%                       -              -                              3,407
 7   To re-elect Richard Bungay as a director                      24,074,907  100%                       -              -                              4,297,543
 8   To re-elect Stuart Gall as a director                         28,371,018  100%                       -              -                              1,432
 9   To re-elect Debra Leeves as a director                        24,074,907  100%                       -              -                              4,297,543
 10  To re-elect Nick Rodgers as a director                        28,371,018  100%                       -              -                              1,432
 11  To elect Jon Kempster as a director                           28,371,018  100%                       -              -                              1,432
 12  Authority to allot shares                                     28,340,996  99.89%                     30,446         0.11%                          1,008
 13  Authority to disapply pre-emption rights(2)                   28,323,483  99.83%                     47,959         0.17%                          1,008
 14  Authority to purchase own shares on the market(2)             24,925,895  99.84%                     39,143         0.16%                          3,407,412

 

 

Notes

1.  Indicates an advisory vote.

2.  Indicates a Special Resolution requiring 75% of votes cast to be carried.

 

 

Enquiries:

 

 Cambridge Cognition Holdings plc                  Tel: 012 2381 0700
 Rob Baker, Joint Managing Director                press@camcog.com (mailto:press@camcog.com)

 and Chief Operating Officer

 Panmure Liberum Limited (NOMAD and Joint Broker)  Tel: 020 7886 2968
 Freddy Crossley / Will Goode / Mark Rogers        (Corporate Finance)
 Rupert Dearden                                    (Corporate Broking)

 Dowgate Capital Limited (Joint Broker)            Tel: 020 3903 7715
 David Poutney / Amber Higgs

 Hudson Sandler (Financial PR and IR)              Tel: 020 7796 4133

 Dan de Belder / Hattie Dreyfus / Jackson Redley   cog@hudsonsandler.com

 

Notes to Editors

 

About Cambridge Cognition

Cambridge Cognition is a brain health software group specialising in digital
health products that advance brain health research and treatment.

 

Built on rich, curated data and deep technical expertise we are building a
strong global brand with scalable technology that will support the rising
world demand for diagnosing and treating brain health. The Company creates
shareholder value through organic sales growth, strategic partnerships, joint
ventures, and spinouts. The Company has identified four market sectors:

·      Clinical Studies for new pharmaceuticals;

·      Academic Research for scientists to understand CNS disorders;

·      Healthcare to provide physicians with cognitive assessments to
allow them to diagnose and treat patients; and,

·      Consumer Health & Wellness to provide individuals access to
accurate, reliable, and meaningful data to assess their cognitive health.

 

For further information, visit: www.cambridgecognition.com/
(http://www.cambridgecognition.com/)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGPKOBBDBKDPAB